Zinc isotopes: a novel approach to biomarkers of breast cancer?

Biomarkers for cancer are essential for diagnosis, prognosis and for predicting the response to specific treatments. Each biomarker has a degree of specificity and sensitivity. For example, estrogen receptors are good biomarkers for breast carcinomas, but there are breast cancers that are estrogen receptor negative, and there are other tumors, e.g., ovarian cancers, which are estrogen receptor positive. As a limited number of cancer biomarkers are specific and sensitive enough for the universal detection of these diseases, there is a constant quest for biomarkers capable of detecting cancers earlier, more reliably and less invasively.

Click here to view full article